The KinematX Midcarpal Total Wrist Arthroplasty Registry

Purpose

The goal of this observational study is to learn about functional and patient reported outcomes in patient undergoing total wrist replacement with the KinematX total wrist replacement study. The main questions it aims to answer are: - What is the range of motion (flexion, extension, radial, ulnar, grip and pinch strength) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant. - What are the patient reported outcomes (PROMIS, PRWE, HSS wrist expectations) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant. - How do range of motion and patient reported outcomes change over the 10 years after total wrist replacement surgery? Participants will be followed according to standard of care and preoperative and post-operative information for up to 10 years after surgery will be collected and entered into an electronic data base. Patients are eligible to enroll into the registry before or after they have had their wrist replacement surgery.

Conditions

  • Scapholunate Advanced Collapse (SLAC)
  • Scapholunate Crystalline Advanced Collapse (SCAC)
  • Scaphoid, Trapezium, and Trapezoid Advanced Collapse (STTAC)
  • Carpal Tunnel Syndrome (CTS)
  • Kienbock's Disease of Adults
  • Radial Malunion
  • Ulnar Translocation
  • Post Traumatic Arthritis
  • Inflammatory Arthritis
  • Osteoarthritis
  • Scaphoid Non-union Advanced Collapse (SNAC)

Eligibility

Eligible Ages
Between 18 Years and 85 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • one of the following diagnoses and planned (or previously completed) total wrist arthroplasty with the KinematX total wrist: - osteoarthritis or post-traumatic arthritis - scapholunate advanced collapse (SLAC/SNAC wrist), - inflammatory arthritis (rheumatoid, psoriatic, other), - crystalline advanced collapse (SCAC), - STT advanced collapse (STTAC), - ulnar translocation, - KienbÓ§ck disease, - radial malunion

Exclusion Criteria

  • <18 years of age - >85 years of age - Prisoners - Children - Pregnant women - Contraindications to receiving the KinematX: - Local, distant or systematic acute or chronic soft tissue or bony infection - Physiologically or psychologically compromised patient - Active wrist synovitis or severe carpal bone erosion - Suspected or documented metal allergy or intolerance - Insufficient extensor tendons - Inadequate skin, bone, neural or vascular status - Severe carpal bone malalignment, displacement, absorption, neoplastic, or carpal bone pathology - Sepsis - Osteomyelitis - Uncontrolled/untreated osteoporosis or metabolic bone disease - Metabolic or endocrinologic bone disorders - Osteomalacia - Distant foci of infections which may spread to the implant site - Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
KinematX patients Patients undergoing total wrist replacement with the KinematX implant.
  • Device: KinematX total wrist arthroplasty system
    The KinematX total wrist implant is a joint metal/polymer semi-constrained cemented prosthesis that utilizes an articulation that mimics the midcarpal joint instead of the radiocarpal joint.

Recruiting Locations

Loma Linda University
Loma Linda, California 92354
Contact:
Elisabeth Clarke
EAClarke@llu.edu

Florida Orthopaedic Institute
Tampa, Florida 33637
Contact:
Debbi Warren
dwarren@foreonline.org

Franciscan Health
Indianapolis, Indiana 46237
Contact:
Stephanie Alford
stephanie.alford@franciscanalliance.org

Hospital for Special Surgery
New York, New York 10021
Contact:
Benjamin Basseri
basserib@hss.edu

More Details

Status
Recruiting
Sponsor
Extremity Medical

Study Contact

Brian Smekal
+1 952-836-5698
bsmekal@extremitymedical.com